Eric Bjerkholt, CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 5,000 shares at $121.67 ($611K) on 2026-07-06, disclosed to the SEC on 2026-07-08.
Scheduled sale ($611k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.67 | 3,124 | $380K | 62.2% |
| 2 | $122.43 | 1,048 | $128K | 21.0% |
| 3 | $123.84 | 528 | $65K | 10.7% |
| 4 | $124.94 | 300 | $37K | 6.1% |
| Total | $122.25 avg | 5,000 | $611K | 100% |
| Filing → |
| CERS | SELL | 2026-06-11 | $53K | — | Filing → |
| MIRM | SELL | 2026-06-09 | $469K | — | Filing → |
| MIRM | SELL | 2026-03-17 | $1.3M | — | Filing → |